Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wanders

Showing results (1-10 of 480) with videos related to

Pageof 48
Sort By:
American Journal of Medical Genetics. Part A|April 21, 2004
Metabolic and molecular basis of peroxisomal disorders: a reviewRonald J A Wanders
Molecular Genetics and Metabolism|October 7, 2004
Peroxisomes, lipid metabolism, and peroxisomal disordersR J A Wanders
Biochimie|September 10, 2013
Metabolic functions of peroxisomes in health and diseaseRonald J A Wanders
Sub-Cellular Biochemistry|July 4, 2013
Peroxisomes in human health and disease: metabolic pathways, metabolite transport, interplay with other organelles and signal transductionRonald J A Wanders
Molecular and Cellular Probes|February 14, 2018
Peroxisomal disorders: Improved laboratory diagnosis, new defects and the complicated route to treatmentRonald J A Wanders
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1992
Enhancement of the effect of low-dose cyclosporin A by sulphasalazine in prevention of cardiac allograft rejection in the ratA Wanders, G Tufveson, B Gerdin
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1992
Effects of prostaglandin E2 (PGE2) and drugs affecting PGE2 degradation on acute rejection of rat cardiac allograftsA Wanders, G Tufveson, B Gerdin
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1988
The enhancing effect of cyclosporine A and sulfasalazine on the prevention of rejection in rat cardiac allograftsA Wanders, G Tufveson, B Gerdin
Molecular Genetics and Metabolism|November 10, 2006
X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatmentStephan Kemp, Ronald J A Wanders
Current Drug Metabolism|September 18, 2012
Peroxisomes, peroxisomal diseases, and the hepatotoxicity induced by peroxisomal metabolitesRonald J A Wanders, Sacha Ferdinandusse
Pageof 48

Showing results (1-10 of 480) with videos related to

Sort By:
Pageof 48
American Journal of Medical Genetics. Part A|April 21, 2004
Metabolic and molecular basis of peroxisomal disorders: a reviewRonald J A Wanders
Molecular Genetics and Metabolism|October 7, 2004
Peroxisomes, lipid metabolism, and peroxisomal disordersR J A Wanders
Biochimie|September 10, 2013
Metabolic functions of peroxisomes in health and diseaseRonald J A Wanders
Sub-Cellular Biochemistry|July 4, 2013
Peroxisomes in human health and disease: metabolic pathways, metabolite transport, interplay with other organelles and signal transductionRonald J A Wanders
Molecular and Cellular Probes|February 14, 2018
Peroxisomal disorders: Improved laboratory diagnosis, new defects and the complicated route to treatmentRonald J A Wanders
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1992
Enhancement of the effect of low-dose cyclosporin A by sulphasalazine in prevention of cardiac allograft rejection in the ratA Wanders, G Tufveson, B Gerdin
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1992
Effects of prostaglandin E2 (PGE2) and drugs affecting PGE2 degradation on acute rejection of rat cardiac allograftsA Wanders, G Tufveson, B Gerdin
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1988
The enhancing effect of cyclosporine A and sulfasalazine on the prevention of rejection in rat cardiac allograftsA Wanders, G Tufveson, B Gerdin
Molecular Genetics and Metabolism|November 10, 2006
X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatmentStephan Kemp, Ronald J A Wanders
Current Drug Metabolism|September 18, 2012
Peroxisomes, peroxisomal diseases, and the hepatotoxicity induced by peroxisomal metabolitesRonald J A Wanders, Sacha Ferdinandusse
Pageof 48